4.6 Article

Developmental changes in human megakaryopoiesis

期刊

JOURNAL OF THROMBOSIS AND HAEMOSTASIS
卷 11, 期 9, 页码 1730-1741

出版社

WILEY
DOI: 10.1111/jth.12326

关键词

cell differentiation; embryonic and fetal development; embryonic stem cell; human development; megakaryocyte; microarray analysis; microRNAs

资金

  1. Agence Nationale de la recherche [ANR-09-BLAN-0275]
  2. Association pour la recherche sur le cancer [ARC 3193]
  3. Labex GR-Ex
  4. program 'Investissements d'avenir'
  5. ANR
  6. Agence Nationale de la Recherche (ANR) [ANR-09-BLAN-0275] Funding Source: Agence Nationale de la Recherche (ANR)

向作者/读者索取更多资源

SummaryBackground The molecular bases of the cellular changes that occur during human megakaryocyte (MK) ontogeny remain unknown, and may be important for understanding the significance of MK differentiation from human embryonic stem cells (hESCs) Methods We optimized the differentiation of MKs from hESCs, and compared these with MKs obtained from primary human hematopoietic tissues at different stages of development. Results Transcriptome analyses revealed a close relationship between hESC-derived and fetal liver-derived MKs, and between neonate-derived and adult-derived MKs. Major changes in the expression profiles of cell cycle and transcription factors (TFs), including MYC and LIN28b, and MK-specific regulators indicated that MK maturation progresses during ontogeny towards an increase in MK ploidy and a platelet-forming function. Important genes, including CXCR4, were regulated by an on-off mechanism during development. Discussion Our analysis of the pattern of TF network and signaling pathways was consistent with a growing specialization of MKs towards hemostasis during ontogeny, and support the idea that MKs derived from hESCs reflect primitive hematopoiesis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Oncology

ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression: one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis

Helene Jakobczyk, Yan Jiang, Lydie Debaize, Benoit Soubise, Stephane Avner, Aurelien A. Serandour, Jeremie Rouger-Gaudichon, Anne-Gaelle Rio, Jason S. Carroll, Hana Raslova, David Gilot, Ziling Liu, Jocelyne Demengeot, Gilles Salbert, Nathalie Douet-Guilbert, Laurent Corcos, Marie-Dominique Galibert, Virginie Gandemer, Marie-Berengere Troadec

LEUKEMIA (2022)

Article Oncology

Reprogramming monocyte-derived macrophages through caspase inhibition

Paul Chaintreuil, Lucie Laplane, Florian Esnault, Victoria Ghesquier, Coline Savy, Nathan Furstoss, Marie-Laure Arcangeli, Thomas Cluzeau, Guillaume Robert, Nathalie Droin, Eric Solary, Patrick Auberger, Arnaud Jacquel

Summary: Macrophages are innate immune cells that play crucial roles in various physiological and pathological processes. Caspases, previously known for their involvement in programmed cell death, are found to have non-apoptotic functions in macrophage differentiation and inflammation. Emricasan, a pan-caspase inhibitor, has shown potential in reprogramming monocyte-derived macrophages and could be an alternative therapy for diseases driven by these macrophages.

ONCOIMMUNOLOGY (2022)

Article Hematology

An inherited gain-of-function risk allele in EPOR predisposes to familial JAK2V617F myeloproliferative neoplasms

Graciela Rabadan Moraes, Florence Pasquier, Christophe Marzac, Eric Deconinck, Carlotta Caterina Damanti, Gwendoline Leroy, Mira El-Khoury, Wassim El Nemer, Jean-Jacques Kiladjian, Hana Raslova, Albert Najman, William Vainchenker, Caroline Marty, Christine Bellanne-Chantelot, Isabelle Plo

Summary: This study identified an EPOR variant in a large family with JAK2-positive MPN, indicating the importance of inherited-risk alleles affecting the JAK2/STAT pathway in MPN. The findings suggest potential implications for risk assessment and treatment of MPN.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Editorial Material Oncology

UNCAN.eu, a European Initiative to UNderstand CANcer

Eric Solary, Patricia Blanc, Michael Boutros, Charis Girvalaki, Franco Locatelli, Rene H. Medema, Peter Nagy, Josep Tabernero

Summary: UNCAN.eu is a European initiative aimed at advancing cancer research through the creation of a research data hub, leading to new developments in cancer care.

CANCER DISCOVERY (2022)

Editorial Material Hematology

ERGonomics for EVI1 acute myeloid leukemia

Cecile K. Lopez, Thomas Mercher

Summary: In this study, the authors used human and murine models to identify genes that are crucial for the survival of ecotropic virus integration site-1 (EVI1)-driven acute myeloid leukemia (AML) cells. They found that ERG is a conserved direct transcriptional target of EVI1, which plays a critical role in promoting cell survival and blocking differentiation in AML cells.
Meeting Abstract Hematology

Subclonal KIT D816V Mutations Are Prevalent in Chronic Myelomonocytic Leukemia and Correlate with Distinct Phenotypic Features

Anthony Hunter, Hannah Newman, Eric Solary, Klaus Geissler, Laura Palomo, Lurdes Zamora, Francesc Sole, Valeria Santini, Timothy A. Graubert, Swapna Thota, Elizabeth A. Griffiths, Lisa Pleyer, Felicitas R. Thol, Rafael Bejar, Luis E. Aguirre, David A. Sallman, Andrew Kuykendall, Rami S. Komrokji, Tracy George, Eric Padron

Article Oncology

High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia

Zakia Aid, Elie Robert, Cecile K. Lopez, Maxence Bourgoin, Fabien Boudia, Melchior Le Mene, Julie Riviere, Marie Baille, Salima Benbarche, Laurent Renou, Alexandre Fagnan, Cecile Thirant, Laetitia Federici, Laure Touchard, Yann Lecluse, Anton Jetten, Birgit Geoerger, Helene Lapillonne, Eric Solary, Muriel Gaudry, Soheil Meshinchi, Francoise Pflumio, Patrick Auberger, Camille Lobry, Arnaud Petit, Arnaud Jacquel, Thomas Mercher

Summary: Pediatric acute myeloid leukemia expressing the ETO2::GLIS2 fusion oncogene has a poor prognosis. The expression of ETO2::GLIS2 leads to activation of CASP3 and increased cell death. Inhibiting both BCL2 and MCL1 is necessary to prevent disease progression in vivo, suggesting a potential therapeutic strategy for this aggressive pediatric AML subgroup.

LEUKEMIA (2023)

Article Biochemistry & Molecular Biology

Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged Tissues

Stephanie Solier, Michele Mondini, Lydia Meziani, Arnaud Jacquel, Catherine Lacout, Tom Vanden Berghe, Yvon Jule, Jean-Claude Martinou, Gerard Pierron, Julie Riviere, Marc Deloger, Corinne Dupuy, Anny Slama-Schwok, Nathalie Droin, Peter Vandenabeele, Patrick Auberger, Eric Deutsch, Jamel El-Benna, Pham My-Chan Dang, Eric Solary

Summary: Circulating monocytes are recruited to damaged tissues to generate macrophages that modulate disease progression. Activation of caspase-3 and caspase-7, located near mitochondria, is involved in the generation of monocyte-derived macrophages stimulated by Colony-stimulating factor-1 (CSF-1). A non-conventional pathway that involves caspases and activates NOX2 is responsible for CSF1-driven monocyte differentiation, and targeting this pathway may have therapeutic implications for modulating macrophage polarization in damaged tissues.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, Research & Experimental

Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases

Vincent Jachiet, Laure Ricard, Pierre Hirsch, Florent Malard, Laurent Pascal, Odile Beyne-Rauzy, Pierre Peterlin, Alexandre Thibault Jacques Maria, Norbert Vey, Maud D'Aveni, Marie-Pierre Gourin, Sophie Dimicoli-Salazar, Anne Banos, Stefan Wickenhauser, Louis Terriou, Benoit De Renzis, Eric Durot, Shanti Natarajan-Ame, Anne Vekhoff, Laurent Voillat, Sophie Park, Julien Vinit, Celine Dieval, Azeddine Dellal, Vincent Grobost, Lise Willems, Julien Rossignol, Eric Solary, Olivier Kosmider, Nicolas Dulphy, Lin Pierre Zhao, Lionel Ades, Pierre Fenaux, Olivier Fain, Mohamad Mohty, Beatrice Gaugler, Arsene Mekinian

Summary: Background systemic inflammatory and autoimmune diseases (SIADs) occur in a significant proportion of myelodysplastic syndrome (MDS) patients. The recently identified VEXAS syndrome, associated with somatic mutations in UBA1, is characterized by severe inflammatory conditions and hematological abnormalities, including MDS. However, the mechanisms underlying the association between MDS and SIADs are largely unknown. This study aimed to evaluate myeloid immune cell subsets in MDS patients with and without SIAD and compare them to healthy controls.

CLINICAL AND EXPERIMENTAL MEDICINE (2023)

Meeting Abstract Medicine, General & Internal

The NFIA-ETO2 fusion blocks terminal erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53

Z. Jevtic, M. R. Pique-Borras, F. Otzen Bagger, J. Seguin, M. Filgueira Bezerra, A. Louwagie, S. Juge, I. Nellas, R. Ivanek, A. Tzankov, U. M. Moll, O. Cantillo, R. Schulz-Heddergott, A. Fagnan, T. Mercher, J. Schwaller

SWISS MEDICAL WEEKLY (2022)

Article Medicine, Research & Experimental

Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model

Brahim Arkoun, Elie Robert, Fabien Boudia, Stefania Mazzi, Virginie Dufour, Aurelie Siret, Yasmine Mammasse, Zakia Aid, Matthieu Vieira, Imanci Aygun, Marine Aglave, Marie Cambot, Rachel Petermann, Sylvie Souquere, Philippe Rameau, Cyril Catelain, Romain Diot, Gerard Tachdjian, Olivier Hermine, Nathalie Droin, Najet Debili, Isabelle Plo, Sebastien Malinge, Eric Soler, Hana Raslova, Thomas Mercher, William Vainchenker

Summary: This study models the clonal evolution of Down syndrome acute megakaryoblastic leukemia (DS-AMKL) and reveals the roles of different mutations in differentiation blockage. The findings demonstrate the significant impact of GATA1s, SMC3, MPL, and T21 mutations on megakaryocyte differentiation and leukemic progression.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Meeting Abstract Pediatrics

Functional characterization of aberrant GATA1 protein complexes in normal and leukemic human erythroblasts

S. Tauchmann, F. O. Bagger, T. Bock, R. Sivalingam, T. Eder, A. Fagnan, M. von Lindern, T. Mercher, F. Grebien, J. Schwaller

KLINISCHE PADIATRIE (2022)

Article Hematology

New insights into regulation of αIIbβ3 integrin signaling by filamin A

Lamia Lamrani, Frederic Adam, Christelle Soukaseum, Cecile Denis, Hana Raslova, Jean-Philippe Rosa, Marijke Bryckaert

Summary: This study evaluates the role of filamin A (FLNa) subdomains in regulating integrin alpha IIb beta 3 signaling. The results show that FLNa-actin and FLNa-beta 3 interactions negatively regulate alpha IIb beta 3 activation, while FLNa dimerization domain negatively regulates alpha IIb beta 3 outside-in signaling.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

Article Multidisciplinary Sciences

Screening of ETO2-GLIS2-induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia

Salima Benbarche, Cecile K. Lopez, Eralda Salataj, Zakia Aid, Cecile Thirant, Marie-Charlotte Laiguillon, Severine Lecourt, Yannis Belloucif, Camille Vaganay, Marion Antonini, Jiang Hu, Alexandra da Silva Babinet, Delphine Ndiaye-Lobry, Bryann Pardieu, Arnaud Petit, Alexandre Puissant, Julie Chaumeil, Thomas Mercher, Camille Lobry

Summary: This study reveals that fusion oncogenes like ETO2-GLIS2 can induce the activation of Super Enhancers (SEs) that regulate essential gene modules synergizing for leukemia progression, promoting the growth and survival of leukemia cells.

SCIENCE ADVANCES (2022)

暂无数据